Adalimumab-induced urticaria.
George
Saira J
SJ
Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA.
Anderson
Heather L
HL
Hsu
Sylvia
S
D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*; D014581:Urticaria / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab